Armin , and Joachim Röhmel. 2002. “The Impact of Sloppy Study Conduct on Noninferiority Studies.” Therapeutic Innovation & Regulatory Science 36(1):3–6. doi: 10.1177/009286150203600102. Sillem, Martin, Sophia [...] Koch, Armin , and Joachim Röhmel. 2001. “Why Are Some Meta-Analyses More Credible than Others?” Therapeutic Innovation & Regulatory Science 35(3):1019–30. doi: 10.1177/009286150103500341. Koch, Armin , Sandra [...] Post-Transplant Lymphoproliferative Disease after Solid Organ Transplant: Characterization of a New Therapeutic Target.” Leukemia and Lymphoma 56(3):832–33. Behrens, Katharina, Melina A. Del Pozo, Anika Großhennig
Lokau J, Garbers C (2025). IL-6 Signaling in Immunopathology: From Basic Biology to Selective Therapeutic Intervention. Review, Immunotargets Ther 2025 Jul 5:14:681-695. doi: 10.2147/ITT.S485684. eCollection [...] PMID: 38217849. (Review) Garbers C , Werfel T (2024). Important molecular differences between therapeutic IL-6 receptor inhibition and its genetic mimicry in patients with AD. J Allergy Clin Immunol. 2024 [...] (2024). Polysialic acid-Siglec immune checkpoints of microglia and macrophages: perspectives for therapeutic intervention. Neural Regen Res. 2024 Dec 16. doi: 10.4103/NRR.NRR-D-24-01195. Online ahead of print
Stanslowsky N., Thau N., Hensel N., Huang D., Claus P., Dengler R., Stangel M., Petri S. (2013): Therapeutic potential of mesenchymal stromal cells and MSC conditioned medium in Amyotrophic Lateral Sclerosis [...] Dec;24(12):2776-91. Grothe, C., Haastert, K., Jungnickel, J. Physiological function and putative therapeutic impact of the FGF-2 system in peripheral nerve regeneration - lessons from in vivo studies in mice
2018 Aug 28;9:1949. doi: 10.3389/fimmu.2018.01949. Endogenous Tumor Suppressor microRNA-193b: Therapeutic and Prognostic Value in Acute Myeloid Leukemia. Bhayadia R, Krowiorz K, Haetscher N, Jammal R,
between the Key Proteins of Serotonin System in SSRI Antidepressants Efficacy“. Expert Opinion on Therapeutic Targets 22 (4): 319–30. https://doi.org/10.1080/14728222.2018.1452912 . Kulikov AV, Gainetdinov
renal or cardiac disorders in Japan. In: 32nd International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2016 August 25-28; Dublin Ireland. Pharmacoepidemiol Drug Saf 25 (Suppl 3), 26 [...] results of a long-term study program [abstract]. In: 32nd Int Conf on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Dublin, Aug 25 – 28, 2016; Pharmacoepidemiol Drug Saf 25 (Suppl 3), 496 [...] Diabetes Patients and Matched Controls. In: 32nd International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2016 August 25-28; Dublin Ireland. Pharmacoepidemiol Drug Saf 25 (Suppl 3), 69
Effects on temporomandibular disorder in the treatment of tension-type headache with acupuncture and therapeutic exercises. A secondary analysis from a randomized controlled trial. Clinical Rehabilitation 2024;
. Haase, A., Ruhparwar, A., and Martin, U. 2025. GMP-compliant manufacturing of iPSC-derived therapeutic cell products: Technologies, applications, risks and limitations. Adv Drug Deliv Rev :115744. [...] Wollert, K. C., Gohla, A., Katus, H. A., Muller, O. J., Bauersachs, J., and Heineke, J. 2019. A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling [...] products. Adv Drug Deliv Rev 120:108. https://doi.org/10.1016/j.addr.2017.09.004 . Martin, U. 2017. Therapeutic Application of Pluripotent Stem Cells: Challenges and Risks. Front Med (Lausanne) 4:229. https://doi
NAKAMURA M: Bilateral sphenoorbital hyperostotic meningiomas with proptosis and visual impairment. a therapeutic challenge. Clinical Neurology and Neurosurgery 113:859-863, 2011. GHAEMI K, MIRZAYAN MJ, KRAUSS [...] G, ESMAEILZADEH M, HARTMANN C, HERMANN EJ, KRAUSS JK. Multiple desmoplastic infantile gliomas-therapeutic challenges. Childs Nerv Syst. 2016 Jan;32(1):17. BAUMERT BG, HEGI ME, VAN DEN BENT MJ, VON DEIMLING [...] HOLTKAMP N. Impaired Pten expression in malignant peripheral nerve sheath tumours and implication for therapeutic intervention with mTOR inhibitors. PLoS One. 2012;7(11):e47595. CAMPOS B, WARTA R, CHAISAINGMONGKOL
PubMed Identification of galectin-3 as a novel potential prognostic/predictive biomarker and therapeutic target for cerebral cavernous malformation disease, Souvik Kar, Andrea Perrelli, Kiran Kumar Bali